Moxilubant (Standard)

Overview

Moxilubant (CGS 25019C free base) Standard is the analytical standard of Moxilubant ( HY-106929 ). This product is intended for research and analytical applications. Moxilubant (CGS 25019C free base) is an orally active BLT1 antagonist. Moxilubant inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant blocks LTB4-induced neutrophil functions. Moxilubant inhibits ear edema and neutrophil infiltration in mice. Moxilubant can be used in research related to chronic obstructive pulmonary disease.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Others | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Leukotriene Receptor | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-106929R
• CAS No.: 146978-48-5
• Molecular Formula: C26H37N3O4
• Molecular Weight: 455.59
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source